載入...
Continuous performance test impairment in a 22q11.2 microdeletion mouse model: improvement by amphetamine
The 22q11.2 deletion syndrome (22q11.2DS) confers high risk of neurodevelopmental disorders such as schizophrenia and attention-deficit hyperactivity disorder. These disorders are associated with attentional impairment, the remediation of which is important for successful therapeutic intervention. W...
Na minha lista:
| 發表在: | Transl Psychiatry |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6235862/ https://ncbi.nlm.nih.gov/pubmed/30429456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41398-018-0295-3 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|